Between September 2016 and October 2016, the company allegedly sold the neurostimulators as reimbursable by Medicare under a code used for implantable neurostimulator devices, according to a Sept. 19 news release.
Those codes are intended for surgically implanted devices, but Azon’s P-Stim (also branded as AnSiStim) are applied with an adhesive and a limited amount of needles without surgery, anesthesia or the help of a surgeon. Medicare doesn’t reimburse for acupuncture or acupuncture devices like AnSiStim or similar devices.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
